Quality‐of‐life scores improve after 96 weeks of PEG‐IFNa‐2a treatment of hepatitis D: An analysis of the HIDIT‐II trial

Liver International · Published 2023-08-01 · Available online 15 May 2023 · Journal article · DOI 10.1111/liv.15602 · Cited by 5 (Crossref)

Authors (31)

Katja Dinkelborg, Julia Kahlhöfer, Petra Dörge, Cihan Yurdaydin, Svenja Hardtke, Florin Alexandru Caruntu, Manuela G. Curescu, Kendal Yalcin, Ulus S. Akarca, Selim Gürel, Stefan Zeuzem, Andreas Erhardt, Stefan Lüth, George Papatheodoridis, Onur Keskin, Kerstin Port, Monica Radu, Mustafa K. Celen, Ramazan Idilman, Kristina Weber, Judith Stift, Ulrike Wittkop, Benjamin Heidrich, Ingmar Mederacke, Heiko von der Leyen, Hans Peter Dienes, Markus Cornberg, Armin Koch, Michael P. Manns, H. Wedemeyer, Katja Deterding

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Volume
43
Issue
8
Pages
1663-1676
Year
2023

Citation

Dinkelborg, K., Kahlhöfer, J., Dörge, P., et al. (2023). Quality‐of‐life scores improve after 96 weeks of PEG‐IFNa‐2a treatment of hepatitis D: An analysis of the HIDIT‐II trial. Liver International. https://doi.org/10.1111/liv.15602

Related articles

Metrics

Citations (Crossref)
5